Related Experiment Video
Updated: Mar 21, 2026
07:44
Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
8.2K
Secreted microRNAs from tumor cells can suppress immune function
Xi Chen1, Hongwei Liang1, Ke Zen1
1Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology (JERC-MBB); State Key Laboratory of Pharmaceutical Biotechnology; School of Life Sciences; Nanjing University ; Nanjing, Jiangsu China.
Oncoimmunology
|May 4, 2016
Summary
Tumor cells secrete microRNAs (miRNAs) to evade the immune system. Blocking these tumor-secreted miRNAs offers a promising new strategy for effective cancer treatment.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Tumor cells employ sophisticated mechanisms to evade host immune surveillance.
- MicroRNAs (miRNAs) are key regulators of gene expression implicated in various biological processes, including cancer.
Purpose of the Study:
- To investigate the role of tumor-secreted microRNAs (miRNAs) in facilitating tumor immune escape.
- To evaluate the therapeutic potential of blocking tumor-secreted miRNA function in cancer treatment.
Main Methods:
- Analysis of miRNA secretion by tumor cells.
- Assessment of the impact of tumor-secreted miRNAs on host immune cells.
- In vivo and in vitro experiments to test the efficacy of miRNA function blockage.
Main Results:
- Demonstration that tumor cells actively secrete miRNAs to manipulate host immune responses.
- Confirmation that these secreted miRNAs contribute to immune escape.
- Evidence that blocking the function of tumor-secreted miRNAs enhances anti-tumor immunity and inhibits tumor growth.
Conclusions:
- Tumor-secreted miRNAs are critical mediators of immune evasion.
- Targeting tumor-secreted miRNAs presents a viable and effective therapeutic strategy for cancer treatment.
- Further research into miRNA-based cancer therapies is warranted.
Related Concept Videos
01:22MicroRNAs
4.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
01:22MicroRNAs
24.6K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.6K
02:17The Tumor Microenvironment
8.1K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.1K
02:17The Tumor Microenvironment
3.0K
3.0K
02:23Abnormal Proliferation
5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
03:03mTOR Signaling and Cancer Progression
5.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
5.0K